TY - JOUR
T1 - Intestinal Foxl1+ cell-derived CXCL12 maintains epithelial homeostasis by modulating cellular metabolism
AU - Yagita-Sakamaki, Mayu
AU - Ito, Takayoshi
AU - Sakaguchi, Taiki
AU - Shimma, Shuichi
AU - Li, Bo
AU - Okuzaki, Daisuke
AU - Motooka, Daisuke
AU - Nakamura, Shota
AU - Hase, Koji
AU - Fukusaki, Eiichiro
AU - Kikuchi, Akira
AU - Nagasawa, Takashi
AU - Kumanogoh, Atsushi
AU - Takeda, Kiyoshi
AU - Kayama, Hisako
N1 - Publisher Copyright:
© The Author(s) 2025. Published by Oxford University Press on behalf of The Japanese Society for Immunology. All rights reserved.
PY - 2025/4/1
Y1 - 2025/4/1
N2 - Several mesenchymal cell populations are known to regulate intestinal stem cell (ISC) self-renewal and differentiation. However, the influences of signaling mediators derived from mesenchymal cells other than ISC niche factors on epithelial homeostasis remain poorly understood. Here, we show that host and microbial metabolites, such as taurine and gamma-aminobutyric acid (GABA), act on PDGFRαhigh Foxl1high sub-epithelial mesenchymal cells to regulate their transcription. In addition, we found that CXC chemokine ligand 12 (CXCL12) produced from Foxl1high sub-epithelial mesenchymal cells induces epithelial cell cycle arrest through modulation of the mevalonate–cholesterol synthesis pathway, which suppresses tumor progression in ApcMin/+ mice. We identified that Foxl1high subepithelial cells highly express CXCL12 among colonic mesenchymal cells. Foxl1-cre; Cxcl12f/f mice showed an increased number of Ki67+ colonic epithelial cells. CXCL12-induced Ca2+ mobilization facilitated phosphorylation of AMPK in intestinal epithelial cells, which inhibits the maturation of sterol regulatory element-binding proteins (SREBPs) that are responsible for mevalonate pathway activation. Furthermore, Cxcl12 deficiency in Foxl1-expressing cells promoted tumor development in the small and large intestines of ApcMin/+ mice. Collectively, these results demonstrate that CXCL12 secreted from Foxl1high mesenchymal cells manipulates intestinal epithelial cell metabolism, which links to the prevention of tumor progression in ApcMin/+ mice.
AB - Several mesenchymal cell populations are known to regulate intestinal stem cell (ISC) self-renewal and differentiation. However, the influences of signaling mediators derived from mesenchymal cells other than ISC niche factors on epithelial homeostasis remain poorly understood. Here, we show that host and microbial metabolites, such as taurine and gamma-aminobutyric acid (GABA), act on PDGFRαhigh Foxl1high sub-epithelial mesenchymal cells to regulate their transcription. In addition, we found that CXC chemokine ligand 12 (CXCL12) produced from Foxl1high sub-epithelial mesenchymal cells induces epithelial cell cycle arrest through modulation of the mevalonate–cholesterol synthesis pathway, which suppresses tumor progression in ApcMin/+ mice. We identified that Foxl1high subepithelial cells highly express CXCL12 among colonic mesenchymal cells. Foxl1-cre; Cxcl12f/f mice showed an increased number of Ki67+ colonic epithelial cells. CXCL12-induced Ca2+ mobilization facilitated phosphorylation of AMPK in intestinal epithelial cells, which inhibits the maturation of sterol regulatory element-binding proteins (SREBPs) that are responsible for mevalonate pathway activation. Furthermore, Cxcl12 deficiency in Foxl1-expressing cells promoted tumor development in the small and large intestines of ApcMin/+ mice. Collectively, these results demonstrate that CXCL12 secreted from Foxl1high mesenchymal cells manipulates intestinal epithelial cell metabolism, which links to the prevention of tumor progression in ApcMin/+ mice.
KW - cancer
KW - gut homeostasis
KW - mesenchymal cells
KW - mevalonate pathway
UR - https://www.scopus.com/pages/publications/86000578395
UR - https://www.scopus.com/pages/publications/86000578395#tab=citedBy
U2 - 10.1093/intimm/dxae068
DO - 10.1093/intimm/dxae068
M3 - Article
C2 - 39774647
AN - SCOPUS:86000578395
SN - 0953-8178
VL - 37
SP - 235
EP - 250
JO - International immunology
JF - International immunology
IS - 4
ER -